Literature DB >> 24918207

Influencing referral of adolescents and young adults with cancer to sites with higher rates of trial enrollment.

Karen H Albritton1, Peter Coccia2.   

Abstract

Adolescents and young adults (AYAs) have lower rates of clinical trial enrollment than younger or older patients with cancer. Multiple approaches to change policy and practice need to be used to improve this statistic. This article examines the option of increasing referral to 3 types of centers that are known to have relatively higher rates of enrollment of AYAs: pediatric cancer centers, AYA oncology programs, and National Cancer Institute-designated cancer centers. There are reasonable challenges to changing referral patterns, and more research, as well as education of those diagnosing AYAs, is required.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  access to health care; adolescent; clinical trial; health services accessibility; neoplasms; referral and consultation; young adult

Mesh:

Year:  2014        PMID: 24918207     DOI: 10.1542/peds.2014-0122E

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital.

Authors:  Stacy D Sanford; Jennifer L Beaumont; Mallory A Snyder; Jennifer Reichek; John M Salsman
Journal:  Support Care Cancer       Date:  2017-01-10       Impact factor: 3.603

2.  Role of clinical trials in survival progress of American adolescents and young adults with cancer-and lack thereof.

Authors:  Archie Bleyer; Eric Tai; Stuart Siegel
Journal:  Pediatr Blood Cancer       Date:  2018-04-18       Impact factor: 3.167

3.  Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.

Authors:  Lori Muffly; Daphne Lichtensztajn; Parveen Shiraz; Renata Abrahão; Jennifer McNeer; Wendy Stock; Theresa Keegan; Scarlett Lin Gomez
Journal:  Cancer       Date:  2016-09-13       Impact factor: 6.921

4.  Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.

Authors:  Rachel G Greenberg; Amy Corneli; John Bradley; John Farley; Hasan S Jafri; Li Lin; Sumathi Nambiar; Gary J Noel; Chris Wheeler; Rosemary Tiernan; P Brian Smith; Jamie Roberts; Daniel K Benjamin
Journal:  Contemp Clin Trials Commun       Date:  2017-11-26

5.  Higher than reported adolescent and young adult clinical trial enrollment during the "Golden Age" of melanoma clinical trials.

Authors:  Radhika Sreeraman Kumar; Ram Thapa; Youngchul Kim; Nikhil I Khushalani; Vernon K Sondak; Damon R Reed
Journal:  Cancer Med       Date:  2018-02-25       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.